From new scientific data-sharing initiatives to US drug tariffs, May brought a range of major news to the pharma landscape.

Please turn to the next slide. After nearly 30 years with Novo Nordisk, Camilla Sylvest decided to step down. Camilla played a pivotal role in establishing our GLP-1 and obesity franchises and be ...

Novo Nordisk (NVO) said Thursday Camilla Sylvest has decided to leave the company, after a distinguished career of 28 years with the drugmaker, seven years as executive vice president of ...

Novo Nordisk has less than 1% of the possible ... along with the rest of the world. Camilla Sylvest, senior vice president for China region, told a telephone press briefing: “We are just getting ...

In fourth quarter results, Camilla Sylvest, commercial strategy and corporate affairs at Novo Nordisk, stated that GLP-1 sales had increased by 36% in North America and outside the US by 57% ...

Novo Nordisk's head of commercial strategy steps down Novo Nordisk's head of commercial strategy and corporate affairs, Camilla Sylvest, has decided to leave the company, the Danish drugmaker said ...

Det har altså nu har ført til en tydelig nedjustering af forventningerne. Derfor forlod Camilla Sylvest Novo Nordisk Når det gælder kommunikationen omkring CagriSema i december lægger Lars Fruergaard ...

Novo Nordisk's head of commercial strategy steps down Novo Nordisk's head of commercial strategy and corporate affairs, Camilla Sylvest, has decided to leave the company, the Danish drugmaker said ...

Novo Nordisk has promoted Rishang Deoras to Global Director ... the industry who have inspired me throughout & had a positive influence on my career - Camilla Sylvest, Tina Abild Olesen, Thomas ...

Grateful and excited to share that after 28 years of being so privileged to work for Novo Nordisk - I have decided to leave this fantastic company. It has been a difficult decision but after ...

Og i begyndelsen af april i år stoppede Novo Nordisks koncerndirektør med ansvar for kommerciel strategi Camilla Sylvest med omgående virkning efter 28 år i selskabet. Ingen af delene har dog haft en ...